09-10, 07:00–07:30 (Europe/Istanbul), Head & Neck Surgery 1
A brief overview of the current understanding of tumor immunology in head and neck cancer will be presented as an introduction. Furthermore, I will discuss our recent findings on tumor vaccine development in head and neck cancer, including the identification of epitopes derived from tumor antigens and the in vivo optimization of a peptide-based vaccine targeting head and neck cancer.
4/2010-9/2012 Research Fellow, Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Japan
9/2012-10/2016 Assistant Professor,Department of Pathology,Asahikawa Medical University, Japan
6/2014-9/2016 Visiting Researcher, Georgia Cancer Center, Augusta University, GA,USA
10/2016-3/2022 Assistant Professor,Department of Innovative Head & Neck Cancer Research andTreatment (IHNCRT),Department of Otolaryngology-Head and Neck Surgery,Asahikawa Medical University, Japan
4/2024-Present Associate Professor,Department of Innovative Head & Neck Cancer Research andTreatment, Department of Otolaryngology-Head and Neck Surgery,Asahikawa Medical University, Japan